Developmental changes in the L-arginine/nitric oxide pathway from infancy to adulthood: plasma asymmetric dimethylarginine levels decrease with age
- 1 January 2007
- journal article
- Published by Walter de Gruyter GmbH in cclm
- Vol. 45 (11), 1525-1530
- https://doi.org/10.1515/cclm.2007.300
Abstract
Clin Chem Lab Med 2007;45:1525–30.Keywords
This publication has 25 references indexed in Scilit:
- Vaso-occlusion in Schimke-immuno-osseous Dysplasia: Is the NO Pathway Involved?Hormone and Metabolic Research, 2006
- Nitric oxide, cell bioenergetics and neurodegenerationJournal of Neurochemistry, 2006
- The discovery of nitric oxide and its role in vascular biologyBritish Journal of Pharmacology, 2006
- Plasma and urine nitric oxide levels in healthy Turkish childrenPediatric Nephrology, 2005
- Asymmetric Dimethylarginine Causes Hypertension and Cardiac Dysfunction in Humans and Is Actively Metabolized by Dimethylarginine DimethylaminohydrolaseArteriosclerosis, Thrombosis, and Vascular Biology, 2003
- NITRIC OXIDE SYNTHASE: Role in the Genesis of Vascular DiseaseAnnual Review of Medicine, 1997
- Detection of NG,NGDimethylarginine Dimethylaminohydrolase in Human Tissues Using a Monoclonal AntibodyThe Journal of Biochemistry, 1995
- Inhibition of nitric oxide synthesis increases blood pressure in healthy humansJournal of Hypertension, 1993
- Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failureThe Lancet, 1992
- Referenzwerte für die Konzentration der freien Aminosäuren im Nüchternserum von KindernKlinische Padiatrie, 1990